Saquayamycin C

• Description:

  Saquayamycin C has antimicrobial effect, but it has weaker effect against Gram-negative bacteria. Saquayamycin C has inhibitory effect on leukemia P388 cells and Adriamycin-resistant P388 cells[1].

• UNSPSC:

  12352005

• Target:

  Bacterial

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Cancer; Infection

• Smiles:

  O=C1C(C=C[C@]2(O)C[C@](O[C@H]3CC[C@@H]([C@@H](O3)C)O[C@H]4CCC([C@@H](O4)C)=O)(C)CC5=O)=C([C@]25O)C(C6=CC=C(C(O)=C16)[C@@H]7O[C@@H]([C@H]([C@@H](C7)O)O[C@@H]8O[C@H](C(CC8)=O)C)C)=O

• Molecular Formula:

  C43H52O16

• Molecular Weight:

  824.86

• References & Citations:

  [1]T Uchida, et al. Saquayamycins, new aquayamycin-group antibiotics. J Antibiot (Tokyo) . 1985 Sep;38 (9) :1171-81.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [99260-70-5]